Inclusion Criteria:~* Meets National Institute of Neurological and Communicative Disorders and
Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) criteria for probable Alzheimer's
Disease~* Completed semagacestat study LFAN or study LFBC through 88 weeks~* Must continue to have a reliable
caregiver~* Capable of swallowing whole oral medication~* Agrees not to participate in other investigational
compounds for the duration of study~
